Keshtkar Somayeh, Asvar Zahra, Najafi Haniyeh, Heidari Mozhdeh, Kaviani Maryam, Sarvestani Fatemeh Sabet, Tamaddon Ali Mohammad, Sadati Maryam Sadat, Hamidizadeh Nasrin, Azarpira Negar
Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Nanotechnology School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
Front Pharmacol. 2025 Apr 28;16:1485769. doi: 10.3389/fphar.2025.1485769. eCollection 2025.
Skin diseases are a broad category of diseases and each has complex conditions, which makes it challenging for dermatologists to provide targeted treatment. Exosomes are natural vesicles secreted by cells and play a key role in cell communication. Due to their unique characteristics, including inherent stability, minimal immunogenicity, high biocompatibility, and exceptional ability to penetrate cells, exosomes are being explored as potential delivery vehicles for therapeutics across various diseases including skin problems. Utilizing exosomes for drug delivery in skin diseases can improve treatment outcomes and reduce the side effects of traditional drug delivery methods. Indeed, exosomes can be engineered or utilized as an innovative approach to deliver therapeutic agents such as small molecule drugs, genes, or proteins specifically to affected skin cells. In addition to targeting specific skin cells or tissues, these engineered exosome-based nanocarriers can reduce off-target effects and improve drug efficacy. Hence, this article highlights the transformative potential of this technology in revolutionizing drug delivery in dermatology and improving patient outcomes.
皮肤疾病是一大类疾病,每种都有复杂的情况,这使得皮肤科医生提供针对性治疗具有挑战性。外泌体是细胞分泌的天然囊泡,在细胞通讯中起关键作用。由于其独特的特性,包括内在稳定性、最小免疫原性、高生物相容性以及出色的细胞穿透能力,外泌体正被探索作为治疗包括皮肤问题在内的各种疾病的潜在药物递送载体。利用外泌体进行皮肤疾病的药物递送可以改善治疗效果并减少传统药物递送方法的副作用。事实上,外泌体可以被设计或用作一种创新方法,将小分子药物、基因或蛋白质等治疗剂特异性地递送至受影响的皮肤细胞。除了靶向特定的皮肤细胞或组织外,这些基于外泌体的工程纳米载体还可以减少脱靶效应并提高药物疗效。因此,本文强调了这项技术在变革皮肤病学药物递送和改善患者治疗效果方面的变革潜力。